Transparency Market Research in its new report titled, “Glycobiology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2026,” provides key insights on glycobiology market. The new report anticipates increasing private and government funding related to proteomics and gylcomics driving the glycobiology market growth during the forecast period i.e, 2016-2026. As per the report, the global glycobiology market is predicted to be driven by the increasing research and development funding on the part of biotechnology and pharmaceutical organizations.
The drug discovery and development division by application was anticipated to hold a major share of the glycobiology market in 2016. The report ascribes the growth of the market to the rise in the evolution of unconventional therapies and drugs through thorough research and development. Other segments such as immunology, oncology, and diagnostics could be listed under the application category.
On the basis of product type segmentation, enzymes are predicted to register a higher CAGR and growth owing to their extensive applications in drug discovery and research and development operations. While they can be further segregated as sialyltransferases, neuraminidases, glycosyltransferases, and glycosidases, the other glycobiology products could be reagents, kits, and instruments. Based on the end-users, a majority share of the global glycobiology market was expected to be secured by academic research institutes in 2016. The success of this end-user segment could be attributed to the strong private and government support offered through funding. Other end users such as contract research organizations and pharmaceutical and biotechnology firms are foretold to stay in the run.
The report has divided the global glycobiology market into North America, Europe, Asia Pacific, and Latin America and Middle East & Africa, out of which, Asia Pacific is predicted to dominate the market riding on a strong CAGR. The demand glycobiology in Asia Pacific could be credited to the rising significance of companion diagnostics, maturing want for customized medicine, and escalating research and development commercialization by biotech and pharma firms.
North America will also register strong growth in terms of growth, mainly due to the increasing incidences of herpes, AIDS, cancer, and other infectious and chronic illnesses. The sedentary lifestyle and multiplying geriatric population in this region is deemed to be responsible for the prevalence of such diseases. Moreover, citizens are being able to access well-assembled reimbursement programs and afford expensive medication, which is expected to further push the rise of North America.
Some of the major players operating in the global glycobiology market are included in this report and these include Waters Corporation, Thermo Fisher Scientific, Takara Bio, Inc., Merck KGaA, Shimadzu Corporation, ProZyme, Inc., New England Biolabs, Danaher Corporation, Bruker Corporation, and Agilent Technologies.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]